切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2013, Vol. 02 ›› Issue (04) : 184 -190. doi: 10.3877/cma.j.issn.2095-3224.2013.03.09.

所属专题: 文献

综述

遗传性结直肠癌的体系结构和诊治进展
丁振1, 顾国利2,()   
  1. 1. 100142 北京,安徽医科大学空军临床学院
    2. 100142 北京,安徽医科大学空军总医院普外科
  • 收稿日期:2013-06-05 出版日期:2013-08-25
  • 通信作者: 顾国利
  • 基金资助:
    全军"十二五"后勤科研课题面上项目(CWS11J193)
  • Received:2013-06-05 Published:2013-08-25
引用本文:

丁振, 顾国利. 遗传性结直肠癌的体系结构和诊治进展[J]. 中华结直肠疾病电子杂志, 2013, 02(04): 184-190.

图1 遗传性结直肠癌的结构体系图
[1]
Kim JC,Kim SY,Roh SA,et al.Gene expression profiling:Canonical molecular changes and clinicopathological features in sporadic colorectal cancers.World J Gastroenterol,2008,14(43):6662-6672.
[2]
陈明清,珠珠,戴莉萍,等.云南省遗传性大肠癌组织库的建立及管理.世界华人消化杂志,2008,16(27):3122-3125.
[3]
韩英.遗传性大肠癌的临床研究现状及进展.临床内科杂志,2007,24(8):519-520.
[4]
顾国利,周晓武,王石林.遗传性非息肉病性大肠癌的研究进展.世界华人消化杂志,2007,15(29):3115-3121.
[5]
Castells A,Balaguer F,Castellví-Bel S,et al.Identification of Lynch syndrome:How should we proceed in the 21st century? World J Gastroenterol,2007,13(33):4413-4416.
[6]
Shen XS,Zhao B,Wang ZJ.Clinical features and hMSH2/hMLH1 germ-line mutations in Chinese patients with hereditary nonpolyposis colorectal cancer.Chin Med J,2008,121(14):1265-1268.
[7]
Meyer LA,Broaddus RR,Lu KH.Endometrial cancer and Lynch syndrome:clinical and pathologic considerations.Cancer Control,2009,16(1):14-22.
[8]
顾国利,魏学明,王石林,等.遗传性非息肉病性大肠癌中hMSH2,hMLH1,TβRⅡ,MMP-7及TIMP-2的表达和其特殊生物学行为间的关系.世界华人消化杂志,2007,15(15):1738-1744.
[9]
顾国利,魏学明,王石林,等.遗传性非息肉病性大肠癌组织E-cad,β-cat和MMP-7表达在侵袭转移中的作用.世界华人消化杂志,2007,15(18):2031-2036.
[10]
顾国利,王石林,魏学明,等.COX-2、β-cat、MMP-7表达与遗传性非息肉病性大肠癌特殊侵袭转移行为的关系.世界华人消化杂志,2009,17(2):151-157.
[11]
Jass JR.Hereditary non-polyposis colorectal cancer:The rise and fall of a confusing term.World J Gastroenterol,2006,12(31):4943-4950.
[12]
Gylling A,Abdel-Rahman WM,Juhola M,et al.Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.Gut,2007,56(7):926-933.
[13]
全国遗传性大肠癌协作组.中国人遗传性大肠癌筛检标准的实施方案.中华肿瘤杂志,2004,26(3):191-192.
[14]
Herráiz M,Muňoz-Navas M.Recognition and management of hereditary colorectal cancer syndromes.Rev Esp Enferm Dig,2009,101(2):125-132.
[15]
Koornstra JJ,Mourits MJ,Sijmons RH,et al.Management of extracolonic tumours in patients with Lynch syndrome.Lancet Oncol,2009,10(4):400-408.
[16]
Kanter-Smoler G,Fritzell K,Rohlin A,et al.Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families.BMC Med,2008,6:10.
[17]
冯莉芳,赖仁胜,刘丽,等.APC基因MCR区突变与大肠肿瘤患者临床发病的关系.世界华人消化杂志,2009,17(5):532-537.
[18]
Wachsmannova-Matelova L,Stevurkova V,Adamcikova Z,et al.Different phenotype manifestation of familial adenomatous polyposis in families with APC mutation at codon 1309.Neoplasma,2009,56(6):486-489.
[19]
Cai SR,Zhang SZ,Zheng S.Clinical features of familial adenomas polyps in Chinese and establishment of its immortal lymphocyte cell lines.World J Gastroenterol,2007,13(20):2858-2861.
[20]
苏芳,王涛,王邦茂.衰减型家族性腺瘤性息肉病.中国消化内镜杂志,2008,2(8):20-26.
[21]
Sieber OM,Segditsas S,Knudsen AL,et al.Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation.Gut,2006,55(10):1440-1448.
[22]
杨邵瑜,蔡善荣,张苏展.家族性腺瘤性息肉病及其亚型的临床及遗传表型.实用肿瘤杂志,2007,22(3):270-273.
[23]
Nielsen M,Hes FJ,Nagengast FM,et al.Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.Clin Genet,2007,71(5):427-433.
[24]
Gómez-Fernández N,Castellví-Bel S,Fernández-Rozadilla C,et al.Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families:a different spectrum of mutations? BMC Med Genet,2009,10:57.
[25]
Poulsen ML,Bisgaard ML.MUTYH Associated Polyposis(MAP).Curr Genomics,2008,9(6):420-435.
[26]
周卉卉,吕炳建,来茂德.遗传性MUTYH基因突变与结直肠癌.浙江大学学报(医学版),2007,34(4):406-411.
[27]
Nielsen M,Joerink-van de MC,Jones N,et al.Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis.Gastroenterology,2009,136(2):471-476.
[28]
Smud D,Augustin G,Kekez T,et al.Gardner's syndrome:Genetic testing and colonoscopy are indicated in adolescents and young adults with cranial osteomas :A case report.World J Gastroenterol,2007,13(28):3900-3903.
[29]
Lipton L,Tomlinson I.The genetics of FAP and FAP-like syndromes.Fam Cancer,2006,5(3):221-226.
[30]
Fotiadis C,Tsekouras DK,Antonakis P,et al.Gardner’s syndrome:A case report and review of the literature.World J Gastroenterol,2005,11(34):5408-5411.
[31]
Gu GL,Wang SL,Wei XM,et al.Diagnosis and treatment of Gardner syndrome with gastric polyposis:a case report and review of the literature.World J Gastroenterol,2008,14(13):2121-2123.
[32]
Reuss D,von Deimling A.Hereditary tumor syndromes and gliomas.Recent Results Cancer Res,2009,171:83-102.
[33]
Lebrun C,Olschwang S,Jeannin S,et al.Turcot syndrome confirmed with molecular analysis.Eur J Neurol,2007,14(4):470-472.
[34]
Sjursen W,Bjφrnevoll I,Engebretsen LF,et al.A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts.Fam Cancer,2009,8(3):179-186.
[35]
Sarin S,Bernath A.Turcot syndrome(glioma polyposis):a case report.South Med J,2008,101(12):1273-1274.
[36]
Wuthrich P,Gervaz P,Ambrosetti P,et al.Functional outcome and quality of life after restorative proctocolectomy and ileo-anal pouch anastomosis.Swiss Med Wkly,2009,139(13-14):193-197.
[37]
Edlich R,Cross CL,Wack CA,et al.Revolutionary advances in the diagnosis and treatment of Familial Adenomatous Polyposis.J Environ Pathol Toxicol Oncol,2009,28(1):47-52.
[38]
Filho OG,Gordan AN,Mello Rde A,et al.Myoid hamartomas of the breast:report of 3 cases and review of the literature.Int J Surg Pathol,2004,12(2):151-153.
[39]
Calva D,Howe JR.Hamartomatous polyposis syndromes.Surg Clin North Am,2008,88(4):779-817.
[40]
王石林,顾国利.Peutz-Jeghers综合征临床诊断治疗的现状和相关问题.世界华人消化杂志,2008,16(21):2385-2389.
[41]
Li LJ,Wang ZQ,Wu BP.Peutz-Jeghers syndrome with small intestinal malignancy and cervical carcinoma.World J Gastroenterol,2008,14(48):7397-7399.
[42]
Hezel AF,Bardeesy N.LKB1,linking cell structure and tumor suppression.Oncogene,2008,27(55):6908-6919.
[43]
Fan D,Ma C,Zhang H.The molecular mechanisms that underlie the tumor suppressor function of LKB1.Acta Biochim Biophys Sin(Shanghai),2009,41(2):97-107.
[44]
Vasovcák P,Puchmajerová A,Roubalík J,et al.Mutations in STK11 gene in Czech Peutz-Jeghers patients.BMC Med Genet,2009,10:69.
[45]
Amos CI,Keitheri-Cheteri MB,Sabripour M,et al.Genotype-phenotype correlations in Peutz-Jeghers syndrome.J Med Genet,2004,41(5):327-333.
[46]
王石林,毛高平,顾国利.Peutz-Jeghers综合征胃肠道息肉的36例诊治经验.中华胃肠外科杂志,2009,12(4):428.
[47]
王石林,顾国利.Peutz-Jeghers综合征胃肠道息肉的药物干预性治疗的进展.中国普外基础与临床杂志,2009,16(4):333-335.
[48]
宁守斌,毛高平,曹传平,等.双气囊小肠镜对Peutz-Jeghers综合征患者小肠息肉的治疗价值.世界华人消化杂志,2008,16(14):1588-1591.
[49]
毛高平,宁守斌,白莉,等.双气囊电子小肠镜在小肠疾病诊断中的应用价值.世界华人消化杂志,2007,15(28):3049-3053.
[50]
Chen HM,Fang JY.Genetics of the hamartomatous polyposis syndromes:a molecular review.Int J Colorectal Dis,2009,24(8):865-874.
[51]
Chow E,Macrae F.A review of juvenile polyposis syndrome.J Gastroenterol Hepatol,2005,20(11):1634-1640.
[52]
姚蓝,宋家武.肠息肉发生的细胞和分子生物学研究进展.世界华人消化杂志,2006,14(30):2958-2961.
[53]
刘剑,李群,陈丽荣,等.家族性幼年性息肉病的家系研究.中华普通外科杂志,2006,21(8):553-556.
[54]
王丽君,宁建文,季峰,等.成人胃幼年性息肉和幼年性息肉病临床病理特征及癌变趋势探讨.中华消化杂志,2005,25(1):43-44.
[55]
Blumenthal GM,Dennis PA.PTEN hamartoma tumor syndromes.Eur J Hum Genet,2008,16(11):1289-1300.
[56]
Umemura K,Takagi S,Ishigaki Y,et al.Gastrointestinal polyposis with esophageal polyposis is useful for early diagnosis of Cowden's disease.World J Gastroenterol,2008,14(37):5755-5759.
[57]
李季,田素礼,李巍,等.结直肠癌中PTEN的缺失表达及临床意义.世界华人消化杂志,2006,14(28):2771-2775.
[58]
刘玉环,王锡智,蔡在龙,等.PTEN基因突变与遗传性癌症综合征及其相关疾病的研究进展.第二军医大学学报,2005,26(1):90-92.
[59]
Blanco V,Keochgerián V.Cowden's syndrome:Case report,with reference to an affected family.Med Oral Patol Oral Cir Bucal,2006,11(1):E12-E16.
[60]
Pilarski R.Cowden syndrome:a critical review of the clinical literature.J Genet Couns,2009,18(1):13-27.
[61]
Leoã JC,Batista V,Guimarães PB,et al.Cowden's syndrome affecting the mouth,gastrointestinal,and central nervous system:a case report and review of the literature.Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2005,99(5):569-572.
[62]
Orloff MS,Eng C.Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.Oncogene,2008,27(41):5387-5397.
[63]
Lachlan KL,Lucassen AM,Bunyan D,et al.Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance:results of a clinical study of PTEN mutation carriers.J Med Genet,2007,44(9):579-585.
[64]
Pezzolesi MG,Platzer P,Waite KA,et al.Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome.Am J Hum Genet,2008,82(5):1141-1149.
[65]
彭慧,曹霞,余光荣,等.华人遗传性混合息肉病综合征BMPR1A基因种系突变检测.中山大学学报(医学科学版),2005,26(3):316-320.
[66]
Cao X,Eu KW,Kumarasinghe MP,et al.Mapping of hereditary mixed polyposis syndrome(HMPS)to chromosome 10q23 by genomewide high-density single nucleotide polymorphism(SNP)scan and identification of BMPR1A loss of function.J Med Genet,2006,43(3):e13.
[67]
Sweet K,Willis J,Zhou XP,et al.Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis.JAMA,2005,294(19):2465-2473.
[68]
彭慧,曹霞,李慧华,等.华人遗传性混合息肉病综合征患者单倍型及遗传连锁分析.中华胃肠外科杂志,2005,8(4):316-319,324.
[69]
魏学明,顾国利,任力,等.大肠癌EGFR、HER-2、VEGF表达特点及其对分子靶向治疗的指导意义.世界华人消化杂志,2009,17(18):1836-1841.
[70]
Takeda H,Miyoshi H,Tamai Y,et al.Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas.Br J Cancer,2004,90(3):701-704.
[71]
Brazowski E,Misonzhnick-Bedny F,Rozen P.Cyclooxygenase-2 expression in the hereditary mixed polyposis syndrome.Dig Dis Sci,2004,49(11-12):1906-1911.
[72]
van Hattem WA,Brosens LA,Marks SY,et al.Increased cyclooxygenase-2 expression in juvenile polyposis syndrome.Clin Gastroenterol Hepatol,2009,7(1):93-97.
[73]
Rosner M,Hanneder M,Siegel N,et al.The mTOR pathway and its role in human genetic diseases.Mutat Res,2008,659(3):284-292.
[74]
Wei C,Amos CI,Zhang N,et al.Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling.Clin Cancer Res,2008,14(4):1167-1171.
[75]
Fujishita T,Aoki K,Lane HA,et al.Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.Proc Natl Acad Sci USA,2008,105(36):13544-13549.
[76]
Höpfner M,Schuppan D,Scherübl H.Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer.World J Gastroenterol,2008,14(1):1-14.
[77]
Roberts RB,Min L,Washington MK,et al.Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.Proc Natl Acad Sci USA,2002,99(3):1521-1526.
[78]
Brugarolas J,Kaelin WG.Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.Cancer Cell,2004,6(1):7-10.
[79]
McGarrity TJ,Peiffer LP,Billingsley ML.Overexpression of epidermal growth factor receptor in Peutz-Jeghers syndrome.Dig Dis Sci,1999,44(6):1136-1141.
[80]
Ylikorkala A,Rossi DJ,Korsisaari N,et al.Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice.Science,2001,293(5533):1323-1326.
[81]
高家信.大肠息肉的中医临床研究概况.现代中西医结合杂志,2001,10(2):117-118.
[82]
李志,陈原,张国英.龚志贤加味济生乌梅丸临床应用举隅.中国中医急症杂志,2002,11(2):151.
[83]
杨炜,徐进康.乌梅用于大肠息肉治疗探讨.中国民族民间医药杂志,2010,19(4):45-48.
[84]
张凤清,方军.肠息肉摘除术后中药灌肠预防复发的疗效观察及护理.护士进修杂志,2002,17(3):200-201.
No related articles found!
阅读次数
全文


摘要